Caixin
Apr 05, 2022 05:37 AM
CHINA

China Clears Two More Homegrown mRNA Vaccines for Clinical Trials

Research on several home-grown Covid-19 vaccines using mRNA technology is underway.
Research on several home-grown Covid-19 vaccines using mRNA technology is underway.

Chinese regulators cleared two domestic vaccine makers to start clinical trials of advanced-technology Covid-19 vaccines, picking up the pace of development to expand the country’s arsenal amid the pandemic’s worst outbreak since 2020.

China's National Medical Products Administration approved clinical trials of a vaccine candidate using the messenger RNA (mRNA) technology developed by Hong Kong-traded vaccine developer CanSino Biologics Inc., the company said Monday.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Stories: Illuminating the Silver Screen for the Visually Impaired
00:00
00:00/00:00